The juvenile Batten disease protein, CLN3, and its role in regulating anterograde and retrograde post-Golgi trafficking. (February 2012)

• Record Type: Journal Article
• Authors: Cotman, Susan L; Staropoli, John F
• Is Part Of: Clinical lipidology. Volume 7:Number 1(2012)
• Page Start: 79
• Page End: 91
• Publication Date: 2012-02
• Subjects: autophagy -- Batten disease -- CLN3 -- endosome -- Golgi -- juvenile neuronal ceroid lipofuscinosis -- lysosome -- palmitoylation; Lipids -- Periodicals; 616.3997
• DOI: 10.2217/clp.11.70
• Languages: English
• ISSNs: 1758-4299

Abstract

Loss-of-function mutations in CLN3 are responsible for juvenile-onset neuronal ceroid lipofuscinosis (JNCL), or Batten disease, which is an incurable lysosomal disease that manifests with vision loss, followed by seizures and progressive neurodegeneration, robbing children of motor skills, speech and cognition, and eventually leading to death in the second or third decade of life. Emerging clinical evidence points to JNCL pathology outside of the CNS, including the cardiovascular system. The CLN3 gene encodes an unusual transmembrane protein, CLN3 or battenin, whose elusive function has been the subject of intense study for more than 10 years. Owing to the detailed characterization of a large number of disease models, our knowledge of CLN3 protein function is finally coming into focus. This review will describe the most current understanding of CLN3 structure, function and dysfunction in JNCL.